Rock Springs Capital Management LP Q3 2022 Filing

Filed November 14, 2022

Portfolio Value

$3.9B

Holdings

127

Report Date

Q3 2022

Filing Type

13F-HR

All Holdings (127 positions)

#	Stock	Shares	Value	% Portfolio	Type
101	OKURRENEO PHARMACEUTICALS INC	1,143,185	$3.8M	0.10%
102	TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC	3,250,000	$3.3M	0.08%
103	ALTALTIMMUNE INC	256,755	$3.3M	0.08%	Call
104	LPTXEURLEAP THERAPEUTICS INC	3,659,847	$3.2M	0.08%
105	FULCFULCRUM THERAPEUTICS INC	384,590	$3.1M	0.08%
106	—BCLS ACQUISITION CORP	309,000	$3.1M	0.08%
107	—THESEUS PHARMACEUTICALS INC	437,329	$2.5M	0.07%
108	ADAPYADAPTIMMUNE THERAPEUTICS PLC	2,357,544	$2.5M	0.07%
109	—ICOSAVAX INC	781,000	$2.5M	0.06%
110	FATEFATE THERAPEUTICS INC	110,000	$2.5M	0.06%
111	SPRBSPRUCE BIOSCIENCES INC	1,622,689	$2.2M	0.06%
112	—JIYA ACQUISITION CORP	206,200	$2.1M	0.05%
113	—IMARA INC	842,402	$1.9M	0.05%
114	AGLEUSDAEGLEA BIOTHERAPEUTICS INC	3,413,906	$1.8M	0.05%
115	SPROSPERO THERAPEUTICS INC	770,710	$1.5M	0.04%
116	—VINCERX PHARMA INC	1,108,570	$1.5M	0.04%
117	OVASUSDTEMPEST THERAPEUTICS INC	823,654	$1.4M	0.04%
118	NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC	1,000,000	$1.4M	0.04%
119	—ACELRX PHARMACEUTICALS INC	6,329,202	$1.3M	0.03%
120	BHVNBIOHAVEN LTD	167,421	$1.1M	0.03%
121	EPIEURESSA PHARMA INC	524,944	$955K	0.02%
122	CGENCOMPUGEN LTD	1,289,990	$848K	0.02%
123	BCELATRECA INC	462,530	$726K	0.02%
124	APLTAPPLIED THERAPEUTICS INC	701,680	$653K	0.02%
125	—PHASEBIO PHARMACEUTICALS INC	2,719,074	$479K	0.01%
126	NVRO 2.75 04/01/25NEVRO CORP	500,000	$473K	0.01%
127	NUVB/WSNUVATION BIO INC	134,028	$27K	0.00%

PreviousPage 2 of 2